Effect of Neurophysiological Facilitation Techniques in Intensive Care Patients

NCT05282576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-03-16

No results posted yet for this study

Summary

The aim of this study was to investigate the effect of neurophysiological facilitation techniques on respiratory and functional levels in intensive care patients. Participants were divided into two groups as experimental (n=20) and control (n=20). Conventional physiotherapy, which includes chest physiotherapy, mobilization exercises and range of motion exercises were applied in control group. Neurophysiological facilitation techniques in addition to the conventional physiotherapy program ere applied in experimental group. The functional status, lower and upper extremity muscle strength, grip strength measurements of the patients and the rates of weaning from mechanical ventilation were evaluated before and after treatment. Vital signs, dyspnea and fatigue perception were assessed each day of treatment. Evaluations were analyzed statistically using Statistical Package for the Social Sciences-22 program.

Conditions

  • Intensive Care (ICU) Myopathy
  • Intensive Care Unit Acquired Weakness

Interventions

OTHER

NPF Group

Participants allocated to the experimental group completed until discharged, neurophysiological facilitation(NPF) techniques in addition to conventional physiotherapy.

OTHER

Control Group

Critical ill patients was applied their conventional physiotherapy which includes chest physiotherapy and mobilization until discharged

Sponsors & Collaborators

  • Medical Park Hospital Istanbul

    collaborator OTHER
  • Saglik Bilimleri Universitesi

    lead OTHER

Principal Investigators

  • Mehmet Burak Uyaroğlu, PT,PhD · Saglik Bilimleri Universitesi

  • Yasemin Çırak, Ass.Prof · Istinye University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-02-01
Completion
2020-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05282576 on ClinicalTrials.gov